Track topics on Twitter Track topics that are important to you
ArcherDX, miRagen, Biodesix Named Finalists for Company of the Year Award; Double Helix, Impressio and Inscripta Nominated for Rising Star Award Leaders of Colorado’s...
The application of next-generation sequencing (NGS) technology in clinical diagnostics should proceed with care. We have evaluated the clinical validity of two commercially available RNA fusion panels...
Intraductal carcinoma (IC) is the new World Health Organization designation for tumors previously called "low-grade cribriform cystadenocarcinoma" and "low-grade salivary duct carcinoma." The relation...
ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored ...
PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments.Â Led by Paul Manning, a successful entrepreneur, the PBM Capital Group partners...
We have published hundreds of ArcherDX, Inc. news stories on BioPortfolio along with dozens of ArcherDX, Inc. Clinical Trials and PubMed Articles about ArcherDX, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ArcherDX, Inc. Companies in our database. You can also find out about relevant ArcherDX, Inc. Drugs and Medications on this site too.
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...